Fixed-Duration Ibrutinib-Venetoclax Promising in First-Line CLL DFS at 1 year reaches 95% in patients with undetectable MRD Dec 06, 2020
Blood Cancers and COVID-19: 'A Medically Vulnerable' Group Patients with hematologic malignancies and SARS-CoV-2 face higher risks for infection, death Dec 06, 2020
These Forbes 400 Billionaires Made Their Fortunes in Healthcare 14 individuals, $66 billion in combined net worth Sep 24, 2020
Raising the Bar for Myelofibrosis Therapy Development Rational combinations, new targets, and a first-ever phase III trial with a survival endpoint Sep 14, 2020
Worse Blood Cancer Outcomes in Hispanics Diagnosis at earlier age, worse survival, especially for those on U.S.-Mexico border Jun 24, 2020
Combination Ups Survival in Older AML Patients Frontline venetoclax plus azacitidine adds 5 months to median OS versus azacitidine alone Jun 17, 2020
Early Palliation: Boon for AML Patients on Intensive Chemo Intervention led to marked improvements in QoL, mental distress, end-of-life care Jun 02, 2020
COVID-19 Mortality Spikes in Patients With Lung, Blood Cancers Those with metastatic disease also at special risk for poor outcomes Apr 28, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
Bringing Transplant to More Patients With AML Conditioning with radiolabeled antibody leads to successful transplantation in 84% of older patients Feb 25, 2020
New CAR-T Makes Case for Aggressive Lymphomas Largest trial to date shows 73% ORR, 53% CR, potential for outpatient treatment Feb 25, 2020
Stem-Cell Transplant Trial Ends in a Draw Similar PFS with haploidentical bone marrow, double unrelated umbilical cord blood Feb 24, 2020
Myeloablative Therapy Prevails in AML Transplant Study Better survival, fewer relapses compared with reduced-intensity conditioning Feb 21, 2020
Better Quality CR With One AML Therapy vs Another? Longer survival after CR/CRi with CPX-351 than with 7+3 in patients with AML-MRC Feb 21, 2020
Gains in Stem Cell Transplant Mortality Over Last 25 Years But outcomes still "far from perfect" Jan 20, 2020
Higher Risk of Shingles Seen in Patients With Certain Cancers Vaccine development may help with prevention of herpes zoster in this population Dec 31, 2019
Survival Bump With Oral AML Maintenance Ten-month OS gain, doubling of RFS with oral azacitidine in transplant-ineligible patients Dec 10, 2019
IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR Prognostic tool may predict who is likely to achieve a relatively long remission Oct 15, 2019
FCR Still an Option in IGHV-Unmutated CLL? Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit Oct 08, 2019
Ibrutinib's Cardiotoxicity Comes Into Focus Study identifies new cardiac events linked to so-called targeted therapy Sep 25, 2019
Overall Survival Data in for Gilteritinib as AML Salvage Tx FLT3 Inhibitor tops chemotherapy in randomized trial Apr 01, 2019
Transplant No Help in Hypodiploid ALL Similar 5-year outcomes with or without HSCT, regardless of MRD status Mar 29, 2019
Are Patients Better Off With Image-Guided Bone Marrow Biopsy? Prospect of sedation has some going to interventional radiology Mar 29, 2019
Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
Higher Risk of Shingles Seen in Patients With Certain Cancers Vaccine development may help with prevention of herpes zoster in this population Dec 14, 2018
ASH Poster Rounds: Obesity Impacts CLL Survival in Women Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib Dec 06, 2018
Chemo-Free Tx Tops Best Option in Younger CLL Patients Improved overall survival and safety with ibrutinib-based therapy Dec 04, 2018
Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapies Studies test addition of targeted agents, immunotherapy Dec 03, 2018
CAR T-Cell Responses Prove Durable in ALL, DLBCL Two studies demonstrate long-term control in relapsed/refractory disease Dec 01, 2018
Sneak Peek at Practice-Changing Research From ASH 2018 "Big trials, big results," plus sickle cell disease and CAR T-cell therapies Nov 30, 2018
Levaquin With Chemo Reduces Bacteremia in Pediatric AML/ALL But no advantage seen among those undergoing transplant Sep 11, 2018
FDA Warns Against Long-Term Zmax Use in Certain Cancer Patients Heightened risk of relapse, death seen in study of stem cell transplant recipients Aug 03, 2018
Decades Later, Mortality for Childhood Transplant Recipients Remains High Elevated risk requires closer follow-up care Jul 27, 2018
Nothing Good for Older Lung Cancer Patients From Add-On Cisplatin Two trials show no survival benefit and more toxicity Jul 26, 2018
Second Transplant vs Donor Lymphocyte Infusion in Relapsed AML Both options viable, benefit more clear in certain groups Jul 12, 2018
FLT3-ITD Inhibitor Improves Survival in Relapsed AML More quizartinib-treated patients went on to stem cell transplant Jun 19, 2018
Ivosidenib Induces Deep Remissions in IDH1-Mutant AML On strength of phase I data, drug appears headed for FDA approval Jun 03, 2018
Algorithm Helps Manage Fever Pediatric cancer patients with non-neutropenic fever could benefit May 08, 2018
